068270
vs
P
214450
068270
Over the past 12 months, Celltrion Inc has outperformed PharmaResearch Co Ltd, delivering a return of +21% compared to the PharmaResearch Co Ltd's +5% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
068270
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Celltrion Inc
KRX:068270
|
212 500
KRW
|
|||||
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
333 000
KRW
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
068270, 214450
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Celltrion Inc
Revenue
|
|||||||||||
|
P
|
PharmaResearch Co Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
068270, 214450
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Celltrion Inc
KRX:068270
|
|||||||||
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Celltrion Inc | ||||
|
P
|
PharmaResearch Co Ltd | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
068270, 214450
Performance Gap
068270, 214450
Performance By Year
068270, 214450
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
